[
  {
    "title": "博拓生物：新冠抗原自测试剂获得FDA紧急使用授权",
    "href": "http://stock.jrj.com.cn/2022/12/25160737236371.shtml",
    "datetime": "2022-12-25 16:07:32",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：新冠病毒抗原自测试剂获美FDA紧急使用授权",
    "href": "http://stock.jrj.com.cn/2022/12/25154337236355.shtml",
    "datetime": "2022-12-25 15:43:30",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：股东李起富完成减持106万股",
    "href": "http://stock.jrj.com.cn/2022/11/04184437113702.shtml",
    "datetime": "2022-11-04 18:44:45",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：拟使用不超6亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/09/23173537017628.shtml",
    "datetime": "2022-09-23 17:35:02",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：多名股东拟减持合计不超2.98%股份",
    "href": "http://stock.jrj.com.cn/2022/09/09173836986969.shtml",
    "datetime": "2022-09-09 17:38:44",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：两款产品获得国内医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/09/06174536977466.shtml",
    "datetime": "2022-09-06 17:45:06",
    "code": "688767"
  },
  {
    "title": "博拓生物披露2022年半年报 实现营收15.24亿元",
    "href": "http://stock.jrj.com.cn/2022/08/30091936950975.shtml",
    "datetime": "2022-08-30 09:19:49",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)半年度净利润7.45亿元、同比增长30.99%",
    "href": "http://stock.jrj.com.cn/2022/08/29182236948241.shtml",
    "datetime": "2022-08-29 18:22:33",
    "code": "688767"
  },
  {
    "title": "博拓生物选举陈音龙担任公司董事长 2021年公司净利8.34亿",
    "href": "http://stock.jrj.com.cn/2022/06/15201036732305.shtml",
    "datetime": "2022-06-15 20:10:52",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：近期取得两项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/06/08163836712575.shtml",
    "datetime": "2022-06-08 16:38:51",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)2021年度权益分派10派30元 股权登记日为6月7日",
    "href": "http://stock.jrj.com.cn/2022/05/31180536693898.shtml",
    "datetime": "2022-05-31 18:05:55",
    "code": "688767"
  },
  {
    "title": "博拓生物：新型冠状病毒抗原检测、猴痘病毒核酸检测试剂获得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/05/27101936683697.shtml",
    "datetime": "2022-05-27 10:19:58",
    "code": "688767"
  },
  {
    "title": "博拓生物：猴痘病毒核酸检测等产品获欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/05/26170536681436.shtml",
    "datetime": "2022-05-26 17:05:30",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：2项产品获得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/05/26165836681394.shtml",
    "datetime": "2022-05-26 16:58:30",
    "code": "688767"
  },
  {
    "title": "博拓生物2022年第一季度净利4.93亿同比增长111.25% 收入规模增长",
    "href": "http://stock.jrj.com.cn/2022/05/03165036544815.shtml",
    "datetime": "2022-05-03 16:50:42",
    "code": "688767"
  },
  {
    "title": "博拓生物2021年净利8.34亿同比增长91.57% 董事长陈音龙薪酬185.41万",
    "href": "http://stock.jrj.com.cn/2022/05/03071136540224.shtml",
    "datetime": "2022-05-03 07:11:42",
    "code": "688767"
  },
  {
    "title": "博拓生物披露2022年一季报 实现营收10.17亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28090736490327.shtml",
    "datetime": "2022-04-28 09:07:44",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：一季度净利润增111.25%至4.93亿元",
    "href": "http://stock.jrj.com.cn/2022/04/27183736485280.shtml",
    "datetime": "2022-04-27 18:37:50",
    "code": "688767"
  },
  {
    "title": "博拓生物：新冠病毒抗原自测试剂在巴西、缅甸获得注册",
    "href": "http://stock.jrj.com.cn/2022/04/19162436398639.shtml",
    "datetime": "2022-04-19 16:24:25",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：新冠病毒抗原自测试剂在巴西、缅甸获得注册",
    "href": "http://stock.jrj.com.cn/2022/04/19161436398588.shtml",
    "datetime": "2022-04-19 16:14:25",
    "code": "688767"
  },
  {
    "title": "博拓生物聘任叶春生为公司副总经理 2021年公司净利8.33亿",
    "href": "http://stock.jrj.com.cn/2022/03/21193034857119.shtml",
    "datetime": "2022-03-21 19:30:50",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：高管杨军亲属短线交易公司股票",
    "href": "http://stock.jrj.com.cn/2022/03/04170334530570.shtml",
    "datetime": "2022-03-04 17:03:13",
    "code": "688767"
  },
  {
    "title": "博拓生物回应“恶意造谣九安医疗”：专家并非公司员工 未参与造谣事件",
    "href": "http://stock.jrj.com.cn/2022/03/01142634504398.shtml",
    "datetime": "2022-03-01 14:26:59",
    "code": "688767"
  },
  {
    "title": "一机构席位买入博拓生物",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/01080734503250.shtml",
    "datetime": "2022-03-01 08:07:11",
    "code": "688767"
  },
  {
    "title": "博拓生物2021年净利8.33亿同比增长91.32% 检测试剂销售业绩持续提升",
    "href": "http://stock.jrj.com.cn/2022/02/25231234468695.shtml",
    "datetime": "2022-02-25 23:12:30",
    "code": "688767"
  },
  {
    "title": "博拓生物2021年预计净利8.1亿-9.1亿同比增加86%-109% 海外新冠检测试剂订单增加",
    "href": "http://stock.jrj.com.cn/2022/01/14215934159410.shtml",
    "datetime": "2022-01-14 21:59:54",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)发布更正公告：2021年度净利润预增86.14%-109.12%",
    "href": "http://stock.jrj.com.cn/2022/01/14185134158754.shtml",
    "datetime": "2022-01-14 18:51:26",
    "code": "688767"
  },
  {
    "title": "博拓生物：预计2021年净利润增加4亿元-4.5亿元",
    "href": "http://stock.jrj.com.cn/2022/01/14182534158589.shtml",
    "datetime": "2022-01-14 18:25:16",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：预计2021年度净利润将增加4亿元-4.5亿元",
    "href": "http://stock.jrj.com.cn/2022/01/14181434158565.shtml",
    "datetime": "2022-01-14 18:14:38",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：存在欧洲、澳洲等新冠产品检测市场竞争激烈等风险",
    "href": "http://stock.jrj.com.cn/2022/01/12211734151648.shtml",
    "datetime": "2022-01-12 21:17:45",
    "code": "688767"
  },
  {
    "title": "博拓生物：新冠自测试剂产品面临激烈市场竞争风险",
    "href": "http://stock.jrj.com.cn/2022/01/12205534151550.shtml",
    "datetime": "2022-01-12 20:55:55",
    "code": "688767"
  },
  {
    "title": "国内疫情多处散点发生促新冠检测板块继续走强，九安医疗、博拓生物涨停",
    "href": "http://stock.jrj.com.cn/2022/01/12100334148856.shtml",
    "datetime": "2022-01-12 10:03:21",
    "code": "688767"
  },
  {
    "title": "博拓生物：公司的新冠病毒抗原快速检测试剂可有效涵盖新型冠状病毒Omicron（B.1.1529）变异株",
    "href": "http://stock.jrj.com.cn/2021/11/29143533937708.shtml",
    "datetime": "2021-11-29 14:35:31",
    "code": "688767"
  },
  {
    "title": "博拓生物：前三季度净利润7.19亿元，同比增长101.88%",
    "href": "http://stock.jrj.com.cn/2021/10/31220833785455.shtml",
    "datetime": "2021-10-31 22:08:26",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)第三季度净利润1.50亿元 同比增长179.93%",
    "href": "http://stock.jrj.com.cn/2021/10/29220633780308.shtml",
    "datetime": "2021-10-29 22:06:28",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：新型冠状病毒(2019-nCoV)抗原自检试剂盒获得澳大利亚TGA注册",
    "href": "http://stock.jrj.com.cn/2021/10/18153833710779.shtml",
    "datetime": "2021-10-18 15:38:14",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：拟使用不超6亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/09/28163633530731.shtml",
    "datetime": "2021-09-28 16:36:53",
    "code": "688767"
  },
  {
    "title": "博拓生物今日登陆科创板，首日涨123.24%",
    "href": "http://stock.jrj.com.cn/2021/09/08175633405031.shtml",
    "datetime": "2021-09-08 17:56:42",
    "code": "688767"
  },
  {
    "title": "今日上市：博拓生物、中铁特货",
    "href": "http://stock.jrj.com.cn/2021/09/08090233402301.shtml",
    "datetime": "2021-09-08 09:02:00",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：将于9月8日在上交所上市",
    "href": "http://stock.jrj.com.cn/2021/09/06190333393617.shtml",
    "datetime": "2021-09-06 19:03:43",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)IPO认购结果：网上网下共弃购1.05万股",
    "href": "http://stock.jrj.com.cn/2021/09/02191433375485.shtml",
    "datetime": "2021-09-02 19:14:50",
    "code": "688767"
  },
  {
    "title": "博拓生物(688767.SH)：国泰君安证裕投资获配115.7742万股、网上摇号中签号共18241个",
    "href": "http://stock.jrj.com.cn/2021/08/31192033363045.shtml",
    "datetime": "2021-08-31 19:20:31",
    "code": "688767"
  },
  {
    "title": "【兑奖啦】科创板上海谊众、博拓生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/08/31191133362986.shtml",
    "datetime": "2021-08-31 19:11:53",
    "code": "688767"
  },
  {
    "title": "今日申购：上海谊众、中粮工科、匠心家居、博拓生物",
    "href": "http://stock.jrj.com.cn/2021/08/30090533349872.shtml",
    "datetime": "2021-08-30 09:05:00",
    "code": "688767"
  },
  {
    "title": "证监会同意博拓生物、卓然股份、国光电气科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2021/07/27210933159840.shtml",
    "datetime": "2021-07-27 21:09:00",
    "code": "688767"
  },
  {
    "title": "鼎阳科技、德冠新材、博拓生物科创板IPO提交注册",
    "href": "http://stock.jrj.com.cn/2021/06/15111732933374.shtml",
    "datetime": "2021-06-15 11:17:24",
    "code": "688767"
  },
  {
    "title": "博拓生物IPO：科创不足主营突变 董秘受让股份价格折半",
    "href": "http://stock.jrj.com.cn/2021/06/04080932872819.shtml",
    "datetime": "2021-06-04 08:09:00",
    "code": "688767"
  },
  {
    "title": "博拓生物过会：今年IPO过关第137家 国泰君安过5单",
    "href": "http://stock.jrj.com.cn/2021/04/29152032479879.shtml",
    "datetime": "2021-04-29 15:20:00",
    "code": "688767"
  },
  {
    "title": "上市委定于4月28日审议博拓生物首发IPO及金博股份再融资事项",
    "href": "http://stock.jrj.com.cn/2021/04/23095232428641.shtml",
    "datetime": "2021-04-23 09:52:29",
    "code": "688767"
  },
  {
    "title": "博拓生物将于4月28日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2021/04/22193132425181.shtml",
    "datetime": "2021-04-22 19:31:00",
    "code": "688767"
  },
  {
    "title": "“疫情增强公司盈利能力”论述是否客观？博拓生物回复科创板IPO二轮问询",
    "href": "http://stock.jrj.com.cn/2021/02/10144331883190.shtml",
    "datetime": "2021-02-10 14:43:52",
    "code": "688767"
  },
  {
    "title": "外销占比超八成 募资逾70%拟用于生产线和研发中心建设 博拓生物科创板IPO已问询 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/11/10173631252097.shtml",
    "datetime": "2020-11-10 17:36:39",
    "code": "688767"
  },
  {
    "title": "营收依赖新冠检测产品 博拓生物业绩持续性存疑",
    "href": "http://stock.jrj.com.cn/2020/10/14002331046739.shtml",
    "datetime": "2020-10-14 00:23:21",
    "code": "688767"
  }
]